Data Integrity and Good Documentation Practice

Data Integrity and Good Documentation Practice

Barcelona, Spain

Course No 15952


Costs

This conference already took place.

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Speakers

Bob McDowall, McDowall Ltd., UK

Stephan Dresen, Warner Chilcott Deutschland GmbH/An Allergan Company, Germany

Rico Schulze, GMP/GDP Inspectorate, Germany

Wolfgang Schumacher, formerly F. Hoffmann-La Roche

Objectives

During this Course you will get to know the principles of Good Documentation Practices in the light of Data Integrity requirements. You will learn

  • How to control blank forms and templates
  • How to maintain data integrity for physical, hybrid and electronic records
  • How to establish a compliant and pragmatic change control process
  • How poor documentation practices and falsification can be detected
  • How to train staff in Good Documentation Practice and Data Integrity
  • How multilingual documents can be managed and controlled
  • How to avoid typical documentation failures
Experts will show what you need to consider to maintain GMP compliant documentation systems throughout their life cycle.

Background

Despite numerous regulatory guidelines poor documentation practice has become more and more a global problem and in most cases it leads to severe violations of data integrity principles. The citations regarding data integrity issues in FDA warning letters have been increasing dramatically over the past 3 years and also European Regulatory Agencies are concerned about data integrity failures in poor documentation not only in companies located in far East but also within Europe.

Both FDA and UK’s MHRA have reacted to this situation by issuing guidances containing clear provisions regarding data integrity and documentation e.g. FDA’s CPG objective 3 which covers the laboratory data integrity audit or MHRA’s Guidance for Industry on Data Integrity. Also WHO has published a guidance which provides provisions for data governance and contains expectations for records in both paper and electronic form.

Target Group

This Education Course is designed for Managers and staff from Manufacturing, QC/QA and Analytical Development Laboratories of pharmaceutical companies and API manufacturers. Laboratory and QA personnel from Contract Research Organisation and Contract Manufacturing Organisations as well as Auditors responsible for performing self-inspections or external audits will also benefit from this course.

Programme

Principles of Good Documentation Practice: What do the Guidelines tell us?

  • GMP regulatory requirements for records
  • MHRA, PIC/S and EU data integrity guidance requirements for good documentation practice
  • WHO guidance for documentation
  • ALCOA principles for laboratory and manufacturing records
Data Intengrity and XML
  • Opportunities of XML
  • Advantages (Single Source, Compliance,...)
  • Risiks (Change Control, ...)
Data Integrity – current inspection findings
  • What is data integrity?
  • Why is it so important?
  • What are the authorities/inspectors doing to identify this issue?
  • What can industry do to prevent such issues?
Data Integrity and digital signatures
  • What exactly is an electronic signature?
  • Advanced vs qualified digital signature
  • Technical implementation
  • Change of Workflows
  • Parallel processes
  • How to manage replacements
Instructions and blank forms – Life cycle and data integrity considerations
  • Why is control of blank or template forms important?
  • FDA requirements for control from 1993 and 2016
  • Process for creation of master templates
  • Process for operational use of blank forms
  • Reconciliation mechanisms
Records – Life Cycle and data integrity issues
  • GMP Record Lifecycle
  • Control Mechanisms
  • Data Integrity for physical vs. electronic Records
  • How to manage record copies without violating DI rules?
Handling hybrid records: Good Documentation Practices for linked paper and electronic records
  • Chapter 4 and 21 CFR 11 regulations for linking signatures to electronic records
  • Are you saving the underlying electronic record?
  • Checks and technical controls to ensure the signature is linked to the record
  • Common pitfalls in record-signature linking
Electronic Documentation Management Systems

GMP-compliant document change management
  • How to establish a compliant and pragmatic change control process?
  • The GMP Document Roadmap
  • Document inventory and reconciliation
  • Industry best practice for Record retention timelines – GMP requirements vs. Knowledge Management
Second Person Review of Batch Records - paper, hybrid and electronic format
  • Importance of a second person review for data integrity
  • What will a reviewer review with paper, hybrid and electronic records?
  • Training for second person review
  • Detection of poor documentation practices and falsification
  • Risk-based second person reviews of records and audit trails
Workshop: Data Integrity and Periodic Review
  • Master Document Control
  • Review of Audit Trails
  • Risk Assessment as Base of Period Definition
How to train staff in Good Documentation Practice and Data Integrity
  • Pre-requisites: data integrity policy with effective training
  • Procedure for good documentation practices is essential
  • Options for training: read and understand, instructor led training (ILT) and ILT with check for understanding
Management and Control of multilingual Documents
  • Part 1: Basics: Workbench, Translation, Synchronisation
  • Part 2: Implementation and Management: Responsibilities, GMP status, Versions, Signatures, Change Control
Typical documentation failures and how to avoid them – key learning points
  • Analysis of FDA 483 and warning letter citations for poor documentation practices
  • Identification of top 5 documentation failures
  • Ways to avoid them e.g. through changes in working practice, training and technical controls

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK